Open AccessA pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patients
Author(s) -
Karma Yangchen,
Ramashanker Siddharth,
Saumyendra Vikram Singh,
Raghuwar Dayal Singh,
Himanshi Aggarwal,
Niraj Mishra,
Shalini Tripathi,
Kirti Srivastava,
Teethraj Verma,
Pradeep Kumar
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.154015
Subject(s) - medicine , mucositis , radiation therapy , adverse effect , trismus , buccal administration , dysphagia , carcinoma , swallowing , common terminology criteria for adverse events , nuclear medicine , surgery , radiology , dentistry
Radiation stents made of Lipowitz metal or cerrobend alloy are commonly used to shield uninvolved tissues from electron beams used in therapeutic radiation treatment of head and neck cancers. However, studies investigating the efficacy of cerrobend shielding stent in patients with unilateral buccal carcinoma remain rare.